File Download
There are no files associated with this item.
Supplementary
- Citations:
- Appears in Collections:
Article: Nature of endothelium-derived relaxing factor: Are there two relaxing mediators?
Title | Nature of endothelium-derived relaxing factor: Are there two relaxing mediators? |
---|---|
Authors | |
Issue Date | 1987 |
Publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://circres.ahajournals.org |
Citation | Circulation Research, 1987, v. 61 n. 5 II SUPPL., p. II-61-II-67 How to Cite? |
Abstract | The role of arachidonic acid in forming endothelium-derived relaxing factor remains controversial. This controversy may be explained if more than one factor exists. To test this hypothesis, the effects of various inhibitors of arachidonic acid metabolism were studied. The perfusate from canine femoral arteries with endothelium was bioassayed with coronary artery rings without endothelium. Treatment of the perfused segment (but not the bioassay ring) with inhibitors of phospholipase A2 (quinacrine) or cytochrome P450 (metyrapone) had no effect on the basal relaxing activity of the effluent; treatment with the inhibitor of lipoxygenase, nordihydroguaiaretic acid, significantly depressed it. With increasing concentrations of acetylcholine, a biphasic concentration-relaxation curve was obtained; the enzyme inhibitors depressed or prevented the first phase but affect the second phase. Infusion of arachidonic acid or soybean lipoxidase directly on the bioassay ring did not cause relaxation; together, they evoked concentration-dependent relaxations. These data suggest that acetylcholine can trigger the release of two chemically different relaxing mediators from the endothelium of the canine femoral artery. One factor may be a product of lipoxygenase (or epoxigenase). The second factor is not a metabolite of arachidonic acid and may be released under basal conditions. The existence of two (or more) chemically different endothelium-derived mediators may help to explain the controversial data regarding the nature of the factor(s). |
Persistent Identifier | http://hdl.handle.net/10722/170472 |
ISSN | 2023 Impact Factor: 16.5 2023 SCImago Journal Rankings: 4.903 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rubanyi, GM | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.date.accessioned | 2012-10-30T06:09:37Z | - |
dc.date.available | 2012-10-30T06:09:37Z | - |
dc.date.issued | 1987 | en_US |
dc.identifier.citation | Circulation Research, 1987, v. 61 n. 5 II SUPPL., p. II-61-II-67 | en_US |
dc.identifier.issn | 0009-7330 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/170472 | - |
dc.description.abstract | The role of arachidonic acid in forming endothelium-derived relaxing factor remains controversial. This controversy may be explained if more than one factor exists. To test this hypothesis, the effects of various inhibitors of arachidonic acid metabolism were studied. The perfusate from canine femoral arteries with endothelium was bioassayed with coronary artery rings without endothelium. Treatment of the perfused segment (but not the bioassay ring) with inhibitors of phospholipase A2 (quinacrine) or cytochrome P450 (metyrapone) had no effect on the basal relaxing activity of the effluent; treatment with the inhibitor of lipoxygenase, nordihydroguaiaretic acid, significantly depressed it. With increasing concentrations of acetylcholine, a biphasic concentration-relaxation curve was obtained; the enzyme inhibitors depressed or prevented the first phase but affect the second phase. Infusion of arachidonic acid or soybean lipoxidase directly on the bioassay ring did not cause relaxation; together, they evoked concentration-dependent relaxations. These data suggest that acetylcholine can trigger the release of two chemically different relaxing mediators from the endothelium of the canine femoral artery. One factor may be a product of lipoxygenase (or epoxigenase). The second factor is not a metabolite of arachidonic acid and may be released under basal conditions. The existence of two (or more) chemically different endothelium-derived mediators may help to explain the controversial data regarding the nature of the factor(s). | en_US |
dc.language | eng | en_US |
dc.publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://circres.ahajournals.org | en_US |
dc.relation.ispartof | Circulation Research | en_US |
dc.subject.mesh | Acetylcholine - Pharmacology | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Arachidonic Acid | en_US |
dc.subject.mesh | Arachidonic Acids - Antagonists & Inhibitors - Metabolism - Pharmacology | en_US |
dc.subject.mesh | Biological Agents - Metabolism - Pharmacology | en_US |
dc.subject.mesh | Biological Assay | en_US |
dc.subject.mesh | Coronary Vessels - Drug Effects - Physiology | en_US |
dc.subject.mesh | Cytochrome P-450 Enzyme System - Antagonists & Inhibitors | en_US |
dc.subject.mesh | Dogs | en_US |
dc.subject.mesh | Endothelium - Drug Effects - Metabolism | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Lipoxygenase - Metabolism - Pharmacology | en_US |
dc.subject.mesh | Lipoxygenase Inhibitors | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Metyrapone - Pharmacology | en_US |
dc.subject.mesh | Muscle Relaxation - Drug Effects | en_US |
dc.subject.mesh | Nitric Oxide | en_US |
dc.subject.mesh | Nordihydroguaiaretic Acid - Pharmacology | en_US |
dc.subject.mesh | Phospholipases A - Antagonists & Inhibitors | en_US |
dc.subject.mesh | Phospholipases A2 | en_US |
dc.subject.mesh | Quinacrine - Pharmacology | en_US |
dc.title | Nature of endothelium-derived relaxing factor: Are there two relaxing mediators? | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 3117406 | - |
dc.identifier.scopus | eid_2-s2.0-0012939643 | en_US |
dc.identifier.volume | 61 | en_US |
dc.identifier.issue | 5 II SUPPL. | en_US |
dc.identifier.spage | II | en_US |
dc.identifier.epage | 61 | en_US |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Rubanyi, GM=7005517991 | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.issnl | 0009-7330 | - |